Swiss Re appoints Robin Spencer as COO of Life and Health Reinsurance to drive operational efficiency and technology integration amid strong financial performance.

Swiss Re's Life Guide update introduces new underwriting guidance for life insurance applicants using repurposed longevity drugs, enhancing risk assessment frameworks and integrating AI tools for improved underwriting decisions.

Swiss Re's August 2025 Life Guide update provides U.S. life insurers with new underwriting guidance on repurposed longevity drugs like metformin and rapamycin, enhancing risk assessment for evolving health trends.

Swiss Re reports 16% net income increase in Q1 2025 despite an 11% insurance revenue decline and significant catastrophe losses, backed by strong underwriting and investment results.

SBLI integrates Swiss Re’s CARE claims decision engine to accelerate and streamline life insurance claims processing, enhancing accuracy, transparency, and beneficiary experience across 49 states and DC.

The life insurance market is poised for significant growth, with Swiss Re projecting a market value of $4.8 trillion by 2035, driven by various socio-economic factors.